229 related articles for article (PubMed ID: 7016959)
1. Plasma aldosterone response to angiotensin II in sodium-restricted elderly subjects with essential hypertension.
Morimoto S; Uchida K; Miyamoto M; Kigoshi T; Morise T; Takimoto H; Takeda R
J Am Geriatr Soc; 1981 Jul; 29(7):302-7. PubMed ID: 7016959
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone responsiveness to angiotensin II after sodium restriction in subjects with low renin essential hypertension.
Takeda R; Morimoto S; Uchida K; Hashiba T; Kigoshi T; Honjo A; Fujimura A
Clin Exp Hypertens A; 1982; 4(6):937-49. PubMed ID: 7047005
[TBL] [Abstract][Full Text] [Related]
3. Responsiveness of plasma aldosterone to angiotensin II in patients with diabetes mellitus.
Morimoto S; Uchida K; Kigoshi T; Hosojima H; Yamamoto I; Azukizawa S
Endocrinol Jpn; 1983 Oct; 30(5):671-8. PubMed ID: 6368211
[TBL] [Abstract][Full Text] [Related]
4. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
Shoback DM; Williams GH; Moore TJ; Dluhy RG; Podolsky S; Hollenberg NK
J Clin Invest; 1983 Dec; 72(6):2115-24. PubMed ID: 6358261
[TBL] [Abstract][Full Text] [Related]
5. Effect of sodium balance and calcium channel-blocking drugs on plasma aldosterone responses to infusion of angiotensin II in normal subjects and patients with essential hypertension.
Anderson GH; Howland T; Domschek R; Streeten DH
J Clin Endocrinol Metab; 1986 Nov; 63(5):1126-35. PubMed ID: 3760114
[TBL] [Abstract][Full Text] [Related]
6. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
Shoback DM; Williams GH; Hollenberg NK; Davies RO; Moore TJ; Dluhy RG
J Clin Endocrinol Metab; 1983 Oct; 57(4):764-70. PubMed ID: 6309884
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine does not blunt the aldosterone and cardiovascular response to angiotensin II and potassium infusion in hypertensive patients.
Terzoli L; Leonetti G; Pedretti R; Bragato R; Sampieri L; Fruscio M; Boselli L; Zanchetti A
J Cardiovasc Pharmacol; 1988 Mar; 11(3):317-20. PubMed ID: 2452924
[TBL] [Abstract][Full Text] [Related]
8. Lack of enhanced responsiveness of plasma 18-hydroxycorticosterone and aldosterone to adrenocorticotropin as well as to angiotensin-II during moderate sodium depletion in type II diabetic subjects with normoreninemia.
Kigoshi T; Iwasaki R; Kaneko M; Nakano S; Azukizawa S; Uchida K; Morimoto S
J Clin Endocrinol Metab; 1991 Jun; 72(6):1200-5. PubMed ID: 1851181
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone regulation in essential hypertension: altered adrenal responsiveness to angiotensin II.
Williams GH; Dluhy RG; Moore TJ
Mayo Clin Proc; 1977 May; 52(5):312-6. PubMed ID: 870773
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II in primary hypertension, relationship to plasma renin activity, aldosterone and urinary electrolytes.
Tolagen K; Karlberg BE
Acta Med Scand; 1979; 205(7):557-62. PubMed ID: 474181
[TBL] [Abstract][Full Text] [Related]
11. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
[TBL] [Abstract][Full Text] [Related]
12. Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension.
Taylor T; Moore TJ; Hollenberg NK; Williams GH
Hypertension; 1984; 6(1):92-9. PubMed ID: 6198274
[TBL] [Abstract][Full Text] [Related]
13. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
Yamamoto Y
Jpn Heart J; 1975 Jul; 16(4):404-20. PubMed ID: 1152295
[TBL] [Abstract][Full Text] [Related]
14. Diminished aldosterone responses to angiotensin II and adrenocorticotropin in hypocalcemic subjects: restoration of responsiveness with normocalcemia.
Brickman AS; Trujillo AL; Gutin MS; Tuck ML
J Clin Endocrinol Metab; 1987 Feb; 64(2):297-303. PubMed ID: 3025245
[TBL] [Abstract][Full Text] [Related]
15. A delayed suppression of the renin-aldosterone axis following saline infusion in human hypertension.
Tuck ML; Williams GH; Dluhy RG; Greenfield M; Moore TJ
Circ Res; 1976 Nov; 39(5):711-7. PubMed ID: 975459
[TBL] [Abstract][Full Text] [Related]
16. Role of the aldosterone system in the salt-sensitivity of patients with benign essential hypertension.
Ishii M; Atarashi K; Ikeda T; Hirata Y; Igari T; Uehara Y; Takagi M; Matsuoka H; Takeda T; Murao S
Jpn Heart J; 1983 Jan; 24(1):79-90. PubMed ID: 6343666
[TBL] [Abstract][Full Text] [Related]
17. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
[TBL] [Abstract][Full Text] [Related]
18. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
Hypertension; 1983; 5(3):368-74. PubMed ID: 6341220
[TBL] [Abstract][Full Text] [Related]
19. Abnormal renin short feedback loop in essential hypertension is reversible with converting enzyme inhibition.
LeBoff Ms; Dluhy RG; Hollenberg NK; Moore TJ; Koletsky RJ; Williams GH
J Clin Invest; 1982 Aug; 70(2):335-41. PubMed ID: 6284799
[TBL] [Abstract][Full Text] [Related]
20. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
